通过ATR/CHK1通路调节来管理肺癌的新视野
Riya Thapa1, Obaid Afzal2, Asif Ahmad Bhat1
1School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India.
Future medicinal chemistry
|October 25, 2023
概括
向阿塔克西亚 (ataxia telangiectasia) 和rad3/检查点激酶1 (ATR/CHK1) 途径显示为肺癌治疗的前景. 目前正在研究ATR/CHK1抑制剂,以克服耐药性并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肺癌仍然是全球癌症死亡的主要原因.
- 分子分析已经完善了肺癌的分类,推进了研究和治疗策略.
- ATAXIA telangiectasia和rad3/checkpoint kinase 1 (ATR/CHK1) 途径对于基因组稳定性至关重要,并与肺癌的发展和耐药性有关.
研究的目的:
- 探索ATR/CHK1通路在肺癌中的作用.
- 审查针对ATR/CHK1通路用于肺癌治疗的潜力.
主要方法:
- 对ATR/CHK1通路的临床和临床前研究的审查.
- 探索ATR和CHK1蛋白在DNA损伤修复中的功能.
主要成果:
- 激活ATR/CHK1通路与肺癌,耐药性和预后不佳有关.
- 针对ATR/CHK1通路在临床前和临床研究中显示出有希望的结果.
结论:
- ATR/CHK1通路是新型肺癌治疗的重要目标.
- ATR/CHK1抑制剂正在积极研究其在肺癌治疗中的治疗潜力.
关键词:
这是一个ATRATRATRATR.一个瑞士克朗.造成的DNA损伤是DNA损伤.在NSCLCLC中,我们可以看到NSCLCLC.在SCLC中,SCLC是最重要的.癌症 癌症 癌症 癌症 癌症肺癌是一种肺癌.更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.3K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K